Funding for this research was provided by:
Canadian Institutes of Health Research (MOP 106662, 201411MFE)
Ontario Research Foundation (RE-04-047)
Heart and Stroke Foundation of Canada
Received: 14 August 2018
Accepted: 15 January 2019
First Online: 28 January 2019
Ethics approval and consent to participate
: All participants provided informed consent prior to participation in the study. This study was approved by the Queen’s University Health Sciences and Affiliated Teaching Hospitals Research Ethics Board (#ANAT042-05), and the University of Calgary’s Conjoint Health Research Ethics Board (#22123).
: All participants provided consent for publication of their data prior to participation in the study.
: SHS is co-founder and chief scientific officer of BKIN Technologies that commercializes the KINARM robot. Authors CRL, TCB, SDB and SPD have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.